- Home
- SBH vs SYRE Comparison
SBH vs SYRE Comparison
Compare SBH & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- SYRE
- Stock Information
- Founded
- SBH 1964
- SYRE 2013
- Country
- SBH United States
- SYRE United States
- Employees
- SBH N/A
- SYRE N/A
- Industry
- SBH Other Specialty Stores
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- SYRE Health Care
- Exchange
- SBH Nasdaq
- SYRE Nasdaq
- Market Cap
- SBH 814.6M
- SYRE 841.4M
- IPO Year
- SBH 2006
- SYRE 2016
- Fundamental
- Price
- SBH $8.17
- SYRE $14.10
- Analyst Decision
- SBH Buy
- SYRE Buy
- Analyst Count
- SBH 6
- SYRE 8
- Target Price
- SBH $12.70
- SYRE $50.00
- AVG Volume (30 Days)
- SBH 1.9M
- SYRE 578.1K
- Earning Date
- SBH 05-12-2025
- SYRE 05-08-2025
- Dividend Yield
- SBH N/A
- SYRE N/A
- EPS Growth
- SBH 4.93
- SYRE N/A
- EPS
- SBH 1.66
- SYRE N/A
- Revenue
- SBH $3,723,624,000.00
- SYRE N/A
- Revenue This Year
- SBH $1.08
- SYRE N/A
- Revenue Next Year
- SBH $1.78
- SYRE N/A
- P/E Ratio
- SBH $4.93
- SYRE N/A
- Revenue Growth
- SBH 0.57
- SYRE N/A
- 52 Week Low
- SBH $7.54
- SYRE $10.91
- 52 Week High
- SBH $14.79
- SYRE $40.49
- Technical
- Relative Strength Index (RSI)
- SBH 48.08
- SYRE 48.32
- Support Level
- SBH $7.90
- SYRE $12.29
- Resistance Level
- SBH $8.37
- SYRE $15.77
- Average True Range (ATR)
- SBH 0.30
- SYRE 1.06
- MACD
- SBH 0.06
- SYRE 0.08
- Stochastic Oscillator
- SBH 49.06
- SYRE 52.08
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.